Rezvilutamide (Rez) versus bicalutamide (Bic) plus androgen-deprivation therapy (ADT) in high-volume, metastatic, hormone-sensitive prostate cancer (mHSPC): 5-year outcomes of the phase 3 CHART trial.

Comeback from long-course ADT with relugolix (rel) and darolutamide (daro) in hormone-sensitive prostate cancer (PC) (CLEARED). This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I.

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

BRITS will be able to skip long Entry/Exit System queues in one European country this summer – and it isn’t Greece. Brits can now use e-gates at borders when ...

Read the full story: I watched people miss flights because of new European travel rule – but it’s an easy fix ...

A group of women who lined up to use a men’s restroom at a highway rest area after the women’s facilities became overcrowded has sparked debate online, with some criticizing the move as an invasion of ...

Online Appointment: If you are looking to make any changes to your Aadhaar card, this news is for you. You can now easily book an online appointment from the comfort of your home, without having to ...

Ferry passengers have been warned they could face long queues and delays travelling through the Port of Dover over the Bank Holiday due to EU border checks. The port is preparing for 18,000 travellers ...